PEOPLE - Changes at MWG Biotech AG (Germany):
This article was originally published in Clinica
Executive Summary
Ebersburg, Germany-based MWG Biotech AG has announced the resignation of Thomas Becker from his position as chairman of the board, effective immediately. Mr Becker has cited personal reasons for his departure. Until a successor is appointed, Dr Wolfgang Pieken will add finance and investor relations to his role as chief officer of US business, and Dr Volker Muschalek will add personal and IT sectors to his COO responsibilites.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.